Exact Sciences (EXAS) Reports Q4 Loss, Tops Revenue Estimates

Exact Sciences (EXAS) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.72 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 49.06%. A quarter ago, it was expected that this molecular diagnostics company would post a loss of $0.49 per share when it actually produced break-even earnings, delivering a surprise of 100%.Over the last four quarters, t ...